xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT06036134</url>
    </required_header>
    <id_info>
      <org_study_id>STUDY00017735</org_study_id>
      <secondary_id>R21HD110837</secondary_id>
      <nct_id>NCT06036134</nct_id>
    </id_info>
    <brief_title>Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents</brief_title>
    <official_title>Reducing Vaccine Hesitancy Among Hispanic Parents of COVID-19 Vaccine-Eligible Children</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Arizona State University</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
      <collaborator>
        <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
        <agency_class>NIH</agency_class>
      </collaborator>
    </sponsors>
    <source>Arizona State University</source>
    <oversight_info>
      <has_dmc>Yes</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        COVID-19 vaccines are available to children over six months, and these vaccines are powerful&#xD;
        tools against this catastrophic pandemic. However, Hispanic/Latino children have lower&#xD;
        COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication&#xD;
        and public health experts proposes a community-based theory-driven intervention that utilizes&#xD;
        culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19&#xD;
        vaccine hesitancy and increase their children's vaccine uptake.&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Among children and adolescents, infection with SARS-CoV-2 (COVID-19) can lead to health&#xD;
        complications (e.g., multisystem inflammatory syndrome, long COVID), hospitalizations, and&#xD;
        death. COVID-19 vaccines are available to children over six months, and these vaccines are&#xD;
        powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have&#xD;
        lower COVID-19 vaccination rates than White non-Hispanic children3 In most southwestern U.S.&#xD;
        states, Hispanic children have the lowest COVID-19 vaccination rates among pediatric&#xD;
        populations. Lower vaccination rates in children are primarily due to parental vaccine&#xD;
        hesitancy. Considerably more work is needed to decrease parental COVID-19 vaccine hesitancy&#xD;
        among Hispanic parents.&#xD;
  &#xD;
        Narrative-based interventions are powerful tools for persuading individuals to enact health&#xD;
        behaviors (vaccination) that require an immediate personal cost (discomfort) for a&#xD;
        longer-term gain (disease immunity). Our current study will examine digital storytelling&#xD;
        (DST), a specific form of culturally-grounded narrative developed via community engagement,&#xD;
        to reduce Hispanic parents' COVID-19 vaccine hesitancy. No research, to our knowledge, has&#xD;
        used digital stories to decrease Hispanic parents' vaccine hesitancy. Therefore, it is&#xD;
        critical to assess which stories resonate with and are most persuasive for those who are&#xD;
        hesitant to have their children receive COVID-19 doses and then explore the impact of an&#xD;
        intervention utilizing these stories on parents' decisions to vaccinate their children&#xD;
        against COVID-19.&#xD;
  &#xD;
        Specific Aims:&#xD;
  &#xD;
        Aim 1: Develop one digital story per participant (n=10; each story lasting 2-3 minutes) in a&#xD;
        DST workshop with a sample of Hispanic parents/ legal guardians converted from being COVID-19&#xD;
        vaccine-hesitant to vaccine-accepting.&#xD;
  &#xD;
        Aim 2: Assess the feasibility and acceptability of a web-based pilot DST intervention vs. an&#xD;
        information-only control among Hispanic parents and legal guardians (n=80) of children who&#xD;
        are not up-to-date with CDC-recommended COVID-19 vaccine doses.&#xD;
  &#xD;
        Exploratory aim: The investigators will explore intervention and control group participants'&#xD;
        (n=80) patterns of pre- to post-intervention change in vaccine uptake perceptions, vaccine&#xD;
        hesitancy, intentions to vaccinate children against COVID-19, and children's vaccine uptake&#xD;
        at two months post-intervention.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Not yet recruiting</overall_status>
    <start_date type="Anticipated">November 1, 2023</start_date>
    <completion_date type="Anticipated">June 30, 2025</completion_date>
    <primary_completion_date type="Anticipated">January 30, 2025</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <primary_purpose>Prevention</primary_purpose>
      <masking>Single (Outcomes Assessor)</masking>
    </study_design_info>
    <primary_outcome>
      <measure>Parental COVID-19 vaccine hesitancy</measure>
      <time_frame>Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)</time_frame>
      <description>Parental COVID-19 vaccine hesitancy will be measured at three time points. The investigators will use a modified version of the Parent Attitudes About Childhood Vaccines (PACV) Survey to assess changes in parental vaccine hesitancy (15 items). Scores range from 0-30, with more points equating to greater vaccine hesitancy. For all responses, vaccine-hesitant responses are equal to 2 points, neutral or unsure responses are worth 1 point, and non-hesitant responses are worth 0 points. There are 2 questions which require a slider response. For these two questions, scores of 0-5 signify vaccine hesitancy (2 points), 6-7 signify unsure/neutral responses (1 point), and 8-10 illustrate non-hesitant scores (0 points).</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Intentions to vaccinate child(ren) against COVID-19</measure>
      <time_frame>Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)</time_frame>
      <description>Measured via a previously validated survey item based on Theory of Planned Behavior constructs, updated to reflect COVID-19 vaccination among children. There is one question about parents' intentions to vaccinate their children. The response option is a 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree, 7 = strongly agree), with 1 signifying no intention to vaccinate and 7 signifying the parent is very likely to vaccinate their child(ren). Higher scores indicate great intentions to vaccinate children against COVID-19.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Child's COVID-19 vaccine uptake</measure>
      <time_frame>T3 (2-months post-intervention)</time_frame>
      <description>Measured with two items (yes/no response options) with one question assessing whether children have received 1 or more doses of COVID-19 vaccines over the past two months. Affirmative responses will equal one point, and &quot;no&quot; responses will equal no points.</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>Parents' attitudes about vaccinating their child(ren) against COVID-19</measure>
      <time_frame>Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)</time_frame>
      <description>Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, five items measuring vaccine attitudes (α = 0.833). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying their negative attitude about vaccinating children against COVID-19, and 7 with more positive attitudes about vaccinating against COVID-19. One item is reverse-coded. Therefore, scores range from 5-35, with higher scores indicating more positive attitudes about vaccinating their children against COVID-19.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Parents' perceived norms about vaccinating their child(ren) against COVID-19</measure>
      <time_frame>Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)</time_frame>
      <description>Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, five items measuring perceived norms, (α = 0.899). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying a lack of perceived norms about vaccinating children against COVID-19, and 7 with stronger perceived norms about vaccinating against COVID-19. Therefore, scores range from 5-35, with higher scores indicating stronger perceived norms about vaccinating their children against COVID-19.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Parents' perceived behavioral control to vaccinate their child(ren) against COVID-19</measure>
      <time_frame>Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)</time_frame>
      <description>Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, four items assessing perceived behavioral control (α = 0.785). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying a lack of perceived behavioral control about vaccinating children against COVID-19, and 7 with stronger perceived behavioral control about vaccinating against COVID-19. Therefore, scores range from 4-28, with higher scores indicating stronger perceived norms about vaccinating their children against COVID-19.</description>
    </secondary_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">90</enrollment>
    <condition>Vaccine-Preventable Diseases</condition>
    <condition>COVID-19 Pandemic</condition>
    <condition>Health-Related Behavior</condition>
    <condition>Health Knowledge, Attitudes, Practice</condition>
    <condition>Narration</condition>
    <arm_group>
      <arm_group_label>Baseline and Digital Storytelling (DST)</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).</description>
    </arm_group>
    <arm_group>
      <arm_group_label>Baseline and Control</arm_group_label>
      <arm_group_type>Active Comparator</arm_group_type>
      <description>Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).</description>
    </arm_group>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>Baseline surveys</intervention_name>
      <description>Baseline surveys contained a series of scaled questions, including sociodemographic variables (age, gender, income, education level, relationship to the child), parental COVID-19 vaccine hesitancy, intentions to vaccinate child against COVID-19, and parents' attitudes, perceived norms, and perceived behavioral control about vaccinating their child against COVID-19,</description>
      <arm_group_label>Baseline and Control</arm_group_label>
      <arm_group_label>Baseline and Digital Storytelling (DST)</arm_group_label>
      <other_name>Baseline questionnaire</other_name>
    </intervention>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>Digital Storytelling Intervention</intervention_name>
      <description>In Aim 1, the investigators are creating intervention materials for Study Aim 2. These intervention materials include ten digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. Each story uses individuals' own brief first-person visual narratives/stories that use digital images, audio recordings, music, and text to document personal experiences.</description>
      <arm_group_label>Baseline and Digital Storytelling (DST)</arm_group_label>
      <other_name>Digital Storytelling</other_name>
      <other_name>Storytelling</other_name>
    </intervention>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>Information Control Intervention</intervention_name>
      <description>The control group participants will receive a CDC COVID-19 vaccine information sheet appropriate for their child's age.</description>
      <arm_group_label>Baseline and Control</arm_group_label>
      <other_name>Control Intervention</other_name>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  self-identifies as Hispanic&#xD;
  &#xD;
            -  is a biological parent or a legal guardian of at least one child under 18 years old&#xD;
  &#xD;
            -  their child(ren) are not vaccinated against up-to-date with COVID-19 vaccine doses&#xD;
  &#xD;
            -  agrees to send and receive a text message and submit a photo of their child's&#xD;
               immunization record for T3 data collection.&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  individuals who do not meet inclusion criteria or are unable/ unwilling to provide&#xD;
               consent.&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Alexis Koskan, Ph.D</last_name>
      <role>Principal Investigator</role>
      <affiliation>Arizona State University</affiliation>
    </overall_official>
    <overall_official>
      <last_name>Sunny W Kim, Ph.D</last_name>
      <role>Principal Investigator</role>
      <affiliation>Arizona State University</affiliation>
    </overall_official>
    <overall_contact>
      <last_name>Alexis Koskan, Ph.D</last_name>
      <phone>602-496-6789</phone>
      <email>Alexis.Koskan@asu.edu</email>
    </overall_contact>
    <overall_contact_backup>
      <last_name>Sunny W Kim, Ph.D</last_name>
      <phone>602-496-6789</phone>
      <email>Sunny.Kim@asu.edu</email>
    </overall_contact_backup>
    <verification_date>September 2023</verification_date>
    <study_first_submitted>September 5, 2023</study_first_submitted>
    <study_first_submitted_qc>September 12, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">September 13, 2023</study_first_posted>
    <last_update_submitted>September 12, 2023</last_update_submitted>
    <last_update_submitted_qc>September 12, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">September 13, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <keyword>COVID-19 Vaccine</keyword>
    <keyword>Digital storytelling</keyword>
    <keyword>Hispanic children</keyword>
    <keyword>Vaccine hesitancy</keyword>
    <keyword>Health disparities</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>COVID-19</mesh_term>
      <mesh_term>Vaccine-Preventable Diseases</mesh_term>
    </condition_browse>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT06036134
  org study id: STUDY00017735
  secondary id: R21HD110837
  nct id: NCT06036134
  lead sponsor: 
  collaborator: 
  has dmc: Yes
  is fda regulated drug: No
  is fda regulated device: No
  COVID-19 vaccines are available to children over six months, and these vaccines are powerful
        tools against this catastrophic pandemic. However, Hispanic/Latino children have lower
        COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication
        and public health experts proposes a community-based theory-driven intervention that utilizes
        culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19
        vaccine hesitancy and increase their children's vaccine uptake.
  Among children and adolescents, infection with SARS-CoV-2 (COVID-19) can lead to health
        complications (e.g., multisystem inflammatory syndrome, long COVID), hospitalizations, and
        death. COVID-19 vaccines are available to children over six months, and these vaccines are
        powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have
        lower COVID-19 vaccination rates than White non-Hispanic children3 In most southwestern U.S.
        states, Hispanic children have the lowest COVID-19 vaccination rates among pediatric
        populations. Lower vaccination rates in children are primarily due to parental vaccine
        hesitancy. Considerably more work is needed to decrease parental COVID-19 vaccine hesitancy
        among Hispanic parents.
  
        Narrative-based interventions are powerful tools for persuading individuals to enact health
        behaviors (vaccination) that require an immediate personal cost (discomfort) for a
        longer-term gain (disease immunity). Our current study will examine digital storytelling
        (DST), a specific form of culturally-grounded narrative developed via community engagement,
        to reduce Hispanic parents' COVID-19 vaccine hesitancy. No research, to our knowledge, has
        used digital stories to decrease Hispanic parents' vaccine hesitancy. Therefore, it is
        critical to assess which stories resonate with and are most persuasive for those who are
        hesitant to have their children receive COVID-19 doses and then explore the impact of an
        intervention utilizing these stories on parents' decisions to vaccinate their children
        against COVID-19.
  
        Specific Aims:
  
        Aim 1: Develop one digital story per participant (n=10; each story lasting 2-3 minutes) in a
        DST workshop with a sample of Hispanic parents/ legal guardians converted from being COVID-19
        vaccine-hesitant to vaccine-accepting.
  
        Aim 2: Assess the feasibility and acceptability of a web-based pilot DST intervention vs. an
        information-only control among Hispanic parents and legal guardians (n=80) of children who
        are not up-to-date with CDC-recommended COVID-19 vaccine doses.
  
        Exploratory aim: The investigators will explore intervention and control group participants'
        (n=80) patterns of pre- to post-intervention change in vaccine uptake perceptions, vaccine
        hesitancy, intentions to vaccinate children against COVID-19, and children's vaccine uptake
        at two months post-intervention.
  allocation: Randomized
  intervention model: Parallel Assignment
  primary purpose: Prevention
  masking: Single (Outcomes Assessor)
  measure: Parental COVID-19 vaccine hesitancy
  time frame: Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)
  description: Parental COVID-19 vaccine hesitancy will be measured at three time points. The investigators will use a modified version of the Parent Attitudes About Childhood Vaccines (PACV) Survey to assess changes in parental vaccine hesitancy (15 items). Scores range from 0-30, with more points equating to greater vaccine hesitancy. For all responses, vaccine-hesitant responses are equal to 2 points, neutral or unsure responses are worth 1 point, and non-hesitant responses are worth 0 points. There are 2 questions which require a slider response. For these two questions, scores of 0-5 signify vaccine hesitancy (2 points), 6-7 signify unsure/neutral responses (1 point), and 8-10 illustrate non-hesitant scores (0 points).
  measure: Intentions to vaccinate child(ren) against COVID-19
  time frame: Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)
  description: Measured via a previously validated survey item based on Theory of Planned Behavior constructs, updated to reflect COVID-19 vaccination among children. There is one question about parents' intentions to vaccinate their children. The response option is a 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree, 7 = strongly agree), with 1 signifying no intention to vaccinate and 7 signifying the parent is very likely to vaccinate their child(ren). Higher scores indicate great intentions to vaccinate children against COVID-19.
  measure: Child's COVID-19 vaccine uptake
  time frame: T3 (2-months post-intervention)
  description: Measured with two items (yes/no response options) with one question assessing whether children have received 1 or more doses of COVID-19 vaccines over the past two months. Affirmative responses will equal one point, and "no" responses will equal no points.
  measure: Parents' attitudes about vaccinating their child(ren) against COVID-19
  time frame: Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)
  description: Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, five items measuring vaccine attitudes (α = 0.833). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying their negative attitude about vaccinating children against COVID-19, and 7 with more positive attitudes about vaccinating against COVID-19. One item is reverse-coded. Therefore, scores range from 5-35, with higher scores indicating more positive attitudes about vaccinating their children against COVID-19.
  measure: Parents' perceived norms about vaccinating their child(ren) against COVID-19
  time frame: Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)
  description: Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, five items measuring perceived norms, (α = 0.899). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying a lack of perceived norms about vaccinating children against COVID-19, and 7 with stronger perceived norms about vaccinating against COVID-19. Therefore, scores range from 5-35, with higher scores indicating stronger perceived norms about vaccinating their children against COVID-19.
  measure: Parents' perceived behavioral control to vaccinate their child(ren) against COVID-19
  time frame: Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)
  description: Measured via a previously validated survey updated to reflect COVID-19 vaccination among children, four items assessing perceived behavioral control (α = 0.785). The response options are 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree,7 = strongly agree), with 1 signifying a lack of perceived behavioral control about vaccinating children against COVID-19, and 7 with stronger perceived behavioral control about vaccinating against COVID-19. Therefore, scores range from 4-28, with higher scores indicating stronger perceived norms about vaccinating their children against COVID-19.
  arm group label: Baseline and Digital Storytelling (DST)
  arm group type: Experimental
  description: Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
  arm group label: Baseline and Control
  arm group type: Active Comparator
  description: Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
  intervention type: Behavioral
  intervention name: Baseline surveys
  description: Baseline surveys contained a series of scaled questions, including sociodemographic variables (age, gender, income, education level, relationship to the child), parental COVID-19 vaccine hesitancy, intentions to vaccinate child against COVID-19, and parents' attitudes, perceived norms, and perceived behavioral control about vaccinating their child against COVID-19,
  arm group label: Baseline and Control
  arm group label: Baseline and Digital Storytelling (DST)
  other name: Baseline questionnaire
  intervention type: Behavioral
  intervention name: Digital Storytelling Intervention
  description: In Aim 1, the investigators are creating intervention materials for Study Aim 2. These intervention materials include ten digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. Each story uses individuals' own brief first-person visual narratives/stories that use digital images, audio recordings, music, and text to document personal experiences.
  arm group label: Baseline and Digital Storytelling (DST)
  other name: Digital Storytelling
  other name: Storytelling
  intervention type: Behavioral
  intervention name: Information Control Intervention
  description: The control group participants will receive a CDC COVID-19 vaccine information sheet appropriate for their child's age.
  arm group label: Baseline and Control
  other name: Control Intervention
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: N/A
  healthy volunteers: Accepts Healthy Volunteers
  last name: Alexis Koskan, Ph.D
  role: Principal Investigator
  affiliation: Arizona State University
  last name: Sunny W Kim, Ph.D
  role: Principal Investigator
  affiliation: Arizona State University
  last name: Alexis Koskan, Ph.D
  phone: 602-496-6789
  email: Alexis.Koskan@asu.edu
  last name: Sunny W Kim, Ph.D
  phone: 602-496-6789
  email: Sunny.Kim@asu.edu
  responsible party type: Sponsor
  mesh term: COVID-19
  mesh term: Vaccine-Preventable Diseases